BSX
Boston Scientific Corp. Earnings Dividend
$56.48
Earnings Summary
Revenue | $5203Mn |
Net Profits | $1337Mn |
Net Profit Margins | 25.7% |
PE Ratio | 23.69 |
Boston Scientific Corp.’s revenue jumped 11.58% since last year same period to $5203Mn in the Q1 2026. On a quarterly growth basis, Boston Scientific Corp. has generated -1.57% fall in its revenue since last 3-months.
Boston Scientific Corp.’s net profit jumped 98.37% since last year same period to $1337Mn in the Q1 2026. On a quarterly growth basis, Boston Scientific Corp. has generated 100.15% jump in its net profits since last 3-months.
Boston Scientific Corp.’s net profit margin jumped 77.78% since last year same period to 25.7% in the Q1 2026. On a quarterly growth basis, Boston Scientific Corp. has generated 103.34% jump in its net profit margins since last 3-months.
Boston Scientific Corp.’s price-to-earnings ratio after this Q1 2026 earnings stands at 23.69.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.79 |
EPS Estimate Current Year | 0.79 |
Boston Scientific Corp.’s earning per share (EPS) estimates for the current quarter stand at 0.79 - a 1.59% jump from last quarter’s estimates.
Boston Scientific Corp.’s earning per share (EPS) estimates for the current year stand at 0.79.
Key Ratios
Earning Per Share (EPS) | 0.8 |
Return on Assets (ROA) | 0.06 |
Return on Equity (ROE) | 0.15 |
Boston Scientific Corp.’s earning per share (EPS) jumped 6.67% since last year same period to 0.8 in the Q1 2026. This indicates that the Boston Scientific Corp. has generated 6.67% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Boston Scientific Corp.’s return on assets (ROA) stands at 0.06.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Boston Scientific Corp.’s return on equity (ROE) stands at 0.15.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-03-31 | 0.79 | 0.8 | 0.96% |




